Pharma

Developing new drugs is a lengthy and costly process that involves extensive research, clinical trials, and regulatory approvals. The high costs of research and the lengthy development timeline can pose financial challenges for pharmaceutical companies.

Navigating the complex regulatory landscape to gain approvals from health authorities such as the FDA or EMA can be challenging. Strict safety and efficacy requirements must be met, and any delays in the approval process can impact market entry and revenue.

Pharmaceutical companies invest significant resources in R&D and innovation. However, patent protection has a limited duration, and when patents expire, generic versions of the drugs can enter the market, leading to reduced market share and pricing pressures.

Setting drug prices that balance affordability for patients while ensuring profitability is a complex challenge. Pharmaceutical companies must also navigate negotiations with government payers, private insurers, and healthcare systems to ensure their medications are accessible to patients.